摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

S-15183a | 686345-39-1

中文名称
——
中文别名
——
英文名称
S-15183a
英文别名
(+/)-S-15183a;(3-heptyl-7-methyl-6,8-dioxoisochromen-7-yl) octanoate
S-15183a化学式
CAS
686345-39-1
化学式
C25H36O5
mdl
——
分子量
416.558
InChiKey
YMXPNDJGGNEMOH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    546.7±50.0 °C(Predicted)
  • 密度:
    1.08±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    30
  • 可旋转键数:
    14
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    69.7
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    S-15183a 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 20.0 ℃ 、101.32 kPa 条件下, 反应 3.0h, 以60%的产率得到3-Heptyl-7-methyl-isochroman-6,8-diol
    参考文献:
    名称:
    S-15183a and b, New Sphingosine Kinase Inhibitors, Produced by a Fungus.
    摘要:
    在筛选鞘氨醇激酶抑制剂的过程中,我们在真菌Zopfiella inermis SANK 15183的培养液中发现两种活性化合物。通过光谱分析,我们确定这两种化合物(分别命名为S-15183a和b)的结构为新氮杂菲酮类代谢产物。S-15183a和b分别以2.5和1.6μM的IC50值抑制大鼠肝脏中的鞘氨醇激酶。S-15183a还能抑制完整血小板中的内源性SPH激酶活性。
    DOI:
    10.7164/antibiotics.54.415
  • 作为产物:
    描述:
    1-壬炔4-二甲氨基吡啶 、 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 gold(lll) acetate 、 四丁基碘化铵三乙胺N,N-二异丙基乙胺三氟乙酸2-碘酰基苯甲酸 作用下, 以 四氢呋喃二氯甲烷1,2-二氯乙烷 为溶剂, 反应 0.02h, 生成 S-15183a
    参考文献:
    名称:
    利用邻炔基苯甲醛的环异构化合成氮杂苯酮和相关分子。
    摘要:
    DOI:
    10.1002/anie.200353037
点击查看最新优质反应信息

文献信息

  • Methods, compositions and compound assays for inhibiting amyloid-beta protein production
    申请人:Merchiers Gerard Pascal
    公开号:US20050277612A1
    公开(公告)日:2005-12-15
    A method for identifying compounds that inhibit amyloid-beta precursor protein processing in cells, comprising contacting a test compound with a SPHK polypeptide, or fragment thereof, and measuring a compound-SPHK property related to the production of amyloid-beta peptide. Cellular assays of the method measure indicators including phosphorylated kinase substrate and/or amyloid beta peptide levels. Therapeutic methods, and pharmaceutical compositions including effective amyloid-beta precursor processing-inhibiting amounts of SPHK expression inhibitors, are useful for treating conditions involving cognitive impairment such as Alzheimer's Disease.
    一种鉴定抑制细胞中淀粉样β前体蛋白加工的化合物的方法,包括将测试化合物与 SPHK 多肽或其片段接触,并测量与淀粉样β肽的产生有关的化合物-SPHK 特性。该方法的细胞测定指标包括磷酸化激酶底物和/或淀粉样 beta 肽水平。治疗方法和药物组合物包括有效的淀粉样β前体加工抑制量的SPHK表达抑制剂,可用于治疗涉及认知障碍的疾病,如阿尔茨海默病。
  • JPH10182627A
    申请人:——
    公开号:JPH10182627A
    公开(公告)日:1998-07-07
  • [EN] METHODS, COMPOSITIONS AND COMPOUND ASSAYS FOR INHIBITING AMYLOID-BETA PROTEIN PRODUCTION<br/>[FR] METHODES, COMPOSITIONS ET DOSAGES DESTINES A L'INHIBITION DE LA PRODUCTION DE PROTEINES BETA-AMYLOIDES
    申请人:GALAPAGOS GENOMICS NV
    公开号:WO2005103692A2
    公开(公告)日:2005-11-03
    A method for identifying compounds that inhibit amyloid-beta precursor protein processing in cells, comprising contacting a test compound with a SPHK polypeptide, or fragment thereof, and measuring a compound-SPHK property related to the production of amyloid-beta peptide. Cellular assays of the method measure indicators including phosphorylated kinase substrate and/or amyloid beta peptide levels. Therapeutic methods, and pharmaceutical compositions including effective amyloid-beta precursor processing-inhibiting amounts of SPHK expression inhibitors, are useful for treating conditions involving cognitive impairment such as Alzheimer’s Disease.
  • Synthesis of Azaphilones and Related Molecules by Employing Cycloisomerization ofo-Alkynylbenzaldehydes
    作者:Jianglong Zhu、Andrew R. Germain、John A. Porco
    DOI:10.1002/anie.200353037
    日期:2004.2.27
  • S-15183a and b, New Sphingosine Kinase Inhibitors, Produced by a Fungus.
    作者:KEITA KONO、MASAHIRO TANAKA、YASUNORI ONO、TSUYOSHI HOSOYA、TAKESHI OGITA、TAKAFUMI KOHAMA
    DOI:10.7164/antibiotics.54.415
    日期:——
    In the course of our screening for inhibitors of sphingosine kinase, we found two active compounds in a culture broth of a fungus, Zopfiella inermis SANK 15183. The structures of the compounds, named S-15183a and b, were elucidated by a combination of spectroscopic analyses to be new azaphilone-type metabolites. S-15183a and b inhibited sphingosine kinase from rat liver with IC50 values of 2.5 and 1.6μM, respectively. S-15183a also inhibited endogenous SPH kinase activity in intact platelets.
    在筛选鞘氨醇激酶抑制剂的过程中,我们在真菌Zopfiella inermis SANK 15183的培养液中发现两种活性化合物。通过光谱分析,我们确定这两种化合物(分别命名为S-15183a和b)的结构为新氮杂菲酮类代谢产物。S-15183a和b分别以2.5和1.6μM的IC50值抑制大鼠肝脏中的鞘氨醇激酶。S-15183a还能抑制完整血小板中的内源性SPH激酶活性。
查看更多

同类化合物

萘啶霉素 苯酚,4-(4-吗啉基磺酰)- 焦曲二醇 核丛青霉素 异色酮VI [(7R)-7-甲基-6,8-二氧代-3-[(E)-丙-1-烯基]异苯并吡喃-7-基]2,4-二羟基-6-甲基苯甲酸酯 (E,E,E)-(-)-7-(乙酰氧基)-3-(1,3,5-庚三烯基)-7-甲基-6H-2-苯并吡喃-6,8(7H)-二酮 (7S,8S)-5-氯-3-[(1E,3E)-3,5-二甲基庚-1,3-二烯基]-7,8-二羟基-7-甲基-8H-异苯并吡喃-6-酮 (7R,8R)-5-氯-3-[(1E,3E,5S)-3,5-二甲基庚-1,3-二烯-1-基]-7,8-二羟基-7-甲基-7,8-二氢-6H-异色烯-6-酮 Komaroviquinone entonaemin A 7-heptanoyloxy-3,7-dimethyl-7,8-dihydro-6H-isochromene-6,8-dione sclerketide B (+)-sclerotiorin 2-formyl-1,2-dihydro-6,7,8-trimethoxyisoquinoline Mitorubrinic acid, (S)- (E)-7-hydroxy-7-methyl-3-(prop-1-en-1-yl)-6H-isochromene-6,8(7H)-dione lunatoic acid A (3-Butyl-7-methyl-6,8-dioxoisochromen-7-yl) 6-chloropyridine-3-carboxylate (3-Cyclopropyl-7-methyl-6,8-dioxoisochromen-7-yl) 6-chloropyridine-3-carboxylate [3-(4-Cyanophenyl)-7-methyl-6,8-dioxoisochromen-7-yl] 6-chloropyridine-3-carboxylate (5-Acetyloxy-3-butyl-7-methyl-6,8-dioxoisochromen-7-yl) 6-chloropyridine-3-carboxylate 6-Chloronicotinic acid [6,8-diketo-7-methyl-3-(3-thienyl)isochromen-7-yl] ester Methyl 4-(7-methyl-6,8-dioxo-7-propanoyloxyisochromen-3-yl)butanoate [3-(4-Methoxy-4-oxidanylidene-butyl)-7-methyl-6,8-bis(oxidanylidene)isochromen-7-yl] 6-chloranylpyridine-3-carboxylate [3-(4-Methoxy-4-oxobutyl)-7-methyl-6,8-dioxoisochromen-7-yl] furan-2-carboxylate 4-(7-Hydrocinnamoyloxy-6,8-diketo-7-methyl-isochromen-3-yl)butyric acid methyl ester 4-O-[3-(4-cyanophenyl)-7-methyl-6,8-dioxoisochromen-7-yl] 1-O-methyl butanedioate 1-O-methyl 4-O-(7-methyl-6,8-dioxo-3-thiophen-3-ylisochromen-7-yl) butanedioate 4-O-(5-acetyloxy-3-butyl-7-methyl-6,8-dioxoisochromen-7-yl) 1-O-methyl butanedioate O4-[3-butyl-7-methyl-6,8-bis(oxidanylidene)isochromen-7-yl] O1-methyl butanedioate tert-butyl N-[4-(7-hydroxy-7-methyl-6,8-dioxoisochromen-3-yl)butyl]carbamate 3-(2-(4-fluorophenyl)-6,8-dimethoxy-1-phenyl-1,2-dihydroisoquinolin-3-yl)oxazolidin-2-one 3-(2-(4-chlorophenyl)-6,8-dimethoxy-1-phenyl-1,2-dihydroisoquinolin-3-yl)oxazolidin-2-one 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-3-((E)-3-hydroxy-propenyl)-7-methyl-6,8-dioxo-7,8-dihydro-6H-isochromen-7-yl ester (-)-mitorubrinic acid 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-3-((E)-2-tert-butoxycarbonyl-vinyl)-7-methyl-6,8-dioxo-7,8-dihydro-6H-isochromen-7-yl ester 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-7-methyl-6,8-dioxo-3-((E)-3-oxo-propenyl)-7,8-dihydro-6H-isochromen-7-yl ester 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-7-methyl-6,8-dioxo-3-((E)-propenyl)-7,8-dihydro-6H-isochromen-7-yl ester (R)-2-(tert-butoxycarbonyl)-6,8-dimethoxy-1,3-dimethyl-1,2-dihydroisoquinoline (R)-6,8-dimethoxy-2-(methoxycarbonyl)-1,3-dimethyl-1,2-dihydroisoquinoline (R,E)-7-hydroxy-7-methyl-3-(prop-1-en-1-yl)-6H-isochromene-6,8(7H)-dione preasperpyranone 7-butyryloxy-5-chloro-3-(3-hydroxypropyl)-7-methyl-6H-isochromene-6,8-dione Isochromophilone VII Isochromophilone III sclerotiorin 7-epi-sclerotiorin 7-episclerotiorin Sclerotiorin